Skip to main content

Research Repository

Advanced Search

2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial

MD, Prof Aron Goldhirsch; PhD, Prof Richard D Gelber; MD, Prof Martine J Piccart-Gebhart; MD, Evandro de Azambuja; MSci, Marion Procter; MD, Prof Thomas M Suter; MD, Prof Christian Jackisch; MD, Prof David Cameron; MD, Harald A Weber; PhD, Dominik Heinzmann; MD, Lissandra Dal Lago; MA, Eleanor McFadden; PhD, Prof Mitch Dowsett; MD, Prof Michael Untch; MD, Luca Gianni; MD, Prof Richard Bell; MD, Prof Claus-Henning Köhne; MD, Anita Vindevoghel; MD, Michael Andersson; MD, A Murray Brunt; MD, Douglas Otero-Reyes; MD, Santai Song; MD, Prof Ian Smith; PhD †, Brian Leyland-Jones; MD †, Prof Jose Baselga

Authors

Prof Aron Goldhirsch MD

Prof Richard D Gelber PhD

Prof Martine J Piccart-Gebhart MD

Evandro de Azambuja MD

Marion Procter MSci

Prof Thomas M Suter MD

Prof Christian Jackisch MD

Prof David Cameron MD

Harald A Weber MD

Dominik Heinzmann PhD

Lissandra Dal Lago MD

Eleanor McFadden MA

Prof Mitch Dowsett PhD

Prof Michael Untch MD

Luca Gianni MD

Prof Richard Bell MD

Prof Claus-Henning Köhne MD

Anita Vindevoghel MD

Michael Andersson MD

Douglas Otero-Reyes MD

Santai Song MD

Prof Ian Smith MD

Brian Leyland-Jones PhD †

Prof Jose Baselga MD †



Citation

MD, P. A. G., PhD, P. R. D. G., MD, P. M. J. P.-G., MD, E. D. A., MSci, M. P., MD, P. T. M. S., MD, P. C. J., MD, P. D. C., MD, H. A. W., PhD, D. H., MD, L. D. L., MA, E. M., PhD, P. M. D., MD, P. M. U., MD, L. G., MD, P. R. B., MD, P. C.-H. K., MD, A. V., MD, M. A., MD, A. M. B., …MD †, P. J. B. (2013). 2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial. The Lancet, 382(9897), 1021-1028. https://doi.org/10.1016/S0140-6736%2813%2961094-6

Journal Article Type Article
Publication Date Sep 21, 2013
Deposit Date Jun 5, 2023
Journal LANCET
Print ISSN 0140-6736
Electronic ISSN 1474-547X
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 382
Issue 9897
Pages 1021-1028
DOI https://doi.org/10.1016/S0140-6736%2813%2961094-6
Public URL https://keele-repository.worktribe.com/output/438941